|
End-of-day quote
Korea S.E.
01/10/2026
|
5-day change | 1st Jan Change | ||
| 8,260.00 KRW | +0.85% |
|
+1.35% | -26.64% |
| 09-21 | Englewood Lab, Inc.(KOSDAQ:A950140) dropped from S&P Global BMI Index | CI |
| 08-11 | Englewood Lab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Englewood Lab, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 99,141 | 170,864 | 101,127 | 264,839 | 135,499 | 223,712 |
| Change | - | 72.34% | -40.81% | 161.89% | -48.84% | 65.1% |
| Enterprise Value (EV) 1 | 111,906 | 189,873 | 115,151 | 259,973 | 127,057 | 200,892 |
| Change | - | 69.67% | -39.35% | 125.77% | -51.13% | 58.11% |
| P/E | 32.2x | 11.4x | 13.9x | 12.8x | 6.9x | 9.02x |
| PBR | 1.63x | 2.11x | 1.09x | 2.3x | 0.94x | 1.36x |
| PEG | - | 0x | -0.3x | 0x | -1.28x | 0.3x |
| Capitalization / Revenue | 0.72x | 1.06x | 0.67x | 1.28x | 0.74x | 1.03x |
| EV / Revenue | 0.82x | 1.18x | 0.76x | 1.26x | 0.7x | 0.93x |
| EV / EBITDA | 9.09x | 8.95x | 8.09x | 7.82x | 5.31x | 4.72x |
| EV / EBIT | 14.2x | 11.2x | 11.7x | 9.01x | 6.76x | 5.38x |
| EV / FCF | 24.2x | -11.3x | 493x | 16.7x | -26.8x | 20x |
| FCF Yield | 4.13% | -8.85% | 0.2% | 6% | -3.73% | 5% |
| Dividend per Share 2 | - | - | - | - | 100 | 201 |
| Rate of return | - | - | - | - | 1.47% | 1.79% |
| EPS 2 | 155.1 | 754.9 | 365.7 | 1,044 | 987.9 | 1,249 |
| Distribution rate | - | - | - | - | 10.1% | 16.1% |
| Net sales 1 | 137,168 | 160,816 | 151,509 | 206,784 | 182,220 | 216,790 |
| EBITDA 1 | 12,307 | 21,209 | 14,230 | 33,249 | 23,912 | 42,601 |
| EBIT 1 | 7,869 | 16,905 | 9,882 | 28,855 | 18,795 | 37,368 |
| Net income 1 | 3,082 | 14,997 | 7,265 | 20,742 | 19,628 | 24,815 |
| Net Debt 1 | 12,766 | 19,010 | 14,023 | -4,865 | -8,442 | -22,820 |
| Reference price 2 | 4,990.00 | 8,600.00 | 5,090.00 | 13,330.00 | 6,820.00 | 11,260.00 |
| Nbr of stocks (in thousands) | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 |
| Announcement Date | 17/3/21 | 16/3/22 | 15/3/23 | 21/3/24 | 20/3/25 | 16/3/26 |
1KRW in Million2KRW
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 120M | |
| 21.15x | 4.04x | 14.79x | 3.05% | 334B | |
| 28.54x | 4.39x | 18.11x | 2.09% | 223B | |
| 17.74x | 2.66x | 11.72x | 3.6% | 128B | |
| 23.26x | 3.46x | 14.55x | 2.51% | 67.39B | |
| 49.91x | 7.23x | 27.86x | 0.31% | 45.14B | |
| 38.12x | 6.13x | 26.61x | 2.45% | 44.8B | |
| 18.14x | 2.58x | 10.74x | 4.9% | 33.08B | |
| 31.19x | 2.36x | 13.24x | 1.73% | 32.63B | |
| 14.14x | 2.31x | 10.68x | 5.47% | 31.38B | |
| Average | 26.91x | 3.91x | 16.48x | 2.9% | 93.96B | |
| Weighted average by Cap. | 24.79x | 3.98x | 16.00x | 2.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A950140 Stock
- Valuation Englewood Lab, Inc.
Select your edition
All financial news and data tailored to specific country editions
